Subscribe To
Cellectis Presents Updated Clinical and Translational Data on BALLI-01 at the European Hematology Association (EHA) 2023
NEW YORK, June 09, 2023 (GLOBE NEWSWIRE) — Cellectis (the “Company”) (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, presented today updated clinical and translational data on its clinical trial BALLI-01 (evaluating UCART22) at the European Hematology Association (EHA) 2023. The […] The post Cellectis Presents Updated Clinical and Translational Data on BALLI-01 at the Europe...
Read More
Content Topics
Cellectis
Presents
Updated
Clinical
Translational
Data
Balli 01 at
European
Hematology
Association
Forex
Posted: Jun 9 2023, 20:30
Author Name: forextv
Views: 081272